Assessing drug-related harm

Affiliations

¹ University of Nottingham, Division of Epidemiology and Public Health, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK. Electronic address: j.britton@virgin.net.
² University of Nottingham, Division of Epidemiology and Public Health, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK.
³ Action on Smoking and Health, London, UK.
⁴ Cancer Research UK Health Behaviour Unit, Department of Epidemiology and Public Health, University College London, London, UK.
⁵ Department of Health Sciences, University of York, York, UK.

Comment

John Britton et al. Lancet. 2007.

. 2007 Jun 2;369(9576):1856-1857.

doi: 10.1016/S0140-6736(07)60842-3.

¹ University of Nottingham, Division of Epidemiology and Public Health, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK. Electronic address: j.britton@virgin.net.
² University of Nottingham, Division of Epidemiology and Public Health, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK.
³ Action on Smoking and Health, London, UK.
⁴ Cancer Research UK Health Behaviour Unit, Department of Epidemiology and Public Health, University College London, London, UK.
⁵ Department of Health Sciences, University of York, York, UK.

No abstract available

Comment on

Development of a rational scale to assess the harm of drugs of potential misuse.
Nutt D, King LA, Saulsbury W, Blakemore C. Nutt D, et al. Lancet. 2007 Mar 24;369(9566):1047-53. doi: 10.1016/S0140-6736(07)60464-4. Lancet. 2007. PMID: 17382831 Review.